You are here

  • Home
  • Archive
  • Volume 6, Issue 8
  • Disregarding the restrictive vial-opening policy for BCG vaccine in Guinea-Bissau: impact and cost-effectiveness for tuberculosis mortality and all-cause mortality in children aged 0–4 years

Article info

Article menu
XML
Original research
Disregarding the restrictive vial-opening policy for BCG vaccine in Guinea-Bissau: impact and cost-effectiveness for tuberculosis mortality and all-cause mortality in children aged 0–4 years

Authors

  • Sanne M Thysen OPEN, Institute of Clinical Research, University of Southern Denmark, Odense, Denmark Bandim Health Project, Bissau, Guinea-Bissau Research Centre for Vitamins and Vaccines, Bandim Health Project, Statens Serum Institut, Copenhagen, Denmark Center for Global Health (GloHAU), Aarhus University, Aarhus, Denmark PubMed articlesGoogle scholar articles
  • Ane Baerent Fisker OPEN, Institute of Clinical Research, University of Southern Denmark, Odense, Denmark Bandim Health Project, Bissau, Guinea-Bissau Research Centre for Vitamins and Vaccines, Bandim Health Project, Statens Serum Institut, Copenhagen, Denmark PubMed articlesGoogle scholar articles
  • Stine Byberg Bandim Health Project, Bissau, Guinea-Bissau Research Centre for Vitamins and Vaccines, Bandim Health Project, Statens Serum Institut, Copenhagen, Denmark PubMed articlesGoogle scholar articles
  • Peter Aaby Bandim Health Project, Bissau, Guinea-Bissau Research Centre for Vitamins and Vaccines, Bandim Health Project, Statens Serum Institut, Copenhagen, Denmark PubMed articlesGoogle scholar articles
  • Partho Roy TB Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine Faculty of Epidemiology and Population Health, London, UK PubMed articlesGoogle scholar articles
  • Richard White TB Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine Faculty of Epidemiology and Population Health, London, UK PubMed articlesGoogle scholar articles
  • Ulla Griffiths Health section, UNICEF, New York, New York, USA PubMed articlesGoogle scholar articles
  • Rebecca C Harris TB Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine Faculty of Epidemiology and Population Health, London, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Sanne M Thysen; s.thysen{at}bandim.org
View Full Text

Citation

Thysen SM, Fisker AB, Byberg S, et al
Disregarding the restrictive vial-opening policy for BCG vaccine in Guinea-Bissau: impact and cost-effectiveness for tuberculosis mortality and all-cause mortality in children aged 0–4 years
BMJ Global Health 2021;6:e006127.

Publication history

  • Received April 27, 2021
  • Accepted July 2, 2021
  • First published August 3, 2021.
Online issue publication 
February 21, 2023

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.